series-b
Stage
3
Investors
About
Sironax is a clinical-stage biotechnology company focused on discovering and developing novel therapies for neurodegenerative, inflammatory, immunologic, metabolic, and rare diseases by targeting key contributors of aging and degeneration.
Explore Sironax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.